Fresenius Medical Care AG (LON:0H9X)

Market Cap	10.73B
Revenue (ttm)	16.01B
Net Income (ttm)	548.33M
Shares Out	n/a
EPS (ttm)	1.87
PE Ratio	19.57
Forward PE	n/a
Dividend	1.02 (2.29%)
Ex-Dividend Date	May 17, 2024

Volume	237,339
Average Volume	98,917
Open	44.56
Previous Close	47.16
Day's Range	43.76 - 45.14
52-Week Range	26.92 - 38.27
Beta	0.86
RSI	37.11
Earnings Date	Feb 25, 2025

About Fresenius Medical Care AG

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 1996
• Employees: 119,845
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0H9X

Financial Performance

In 2023, Fresenius Medical Care AG's revenue was 19.45 billion, an increase of 0.29% compared to the previous year's 19.40 billion. Earnings were 499.00 million, a decrease of -25.90%.

Financial numbers in EUR